According to research, it’s possible that older women who
have been diagnosed with an irregular heartbeat are at higher risk of stroke
than men.
A recent study led by the Research Institute of the McGill
University Health Centre shows that warfarin, the most common anticoagulant
therapy used to prevent stroke in patients with atrial fibrillation, may not be
as effective in women, 75 years or older, as in men.
“Our results suggest
that elderly women with atrial fibrillation may need to be targeted for more
effective stroke prevention therapy,” said Dr. Louise Pilote, corresponding
author of the study and researcher in epidemiology at McGill. “Knowing the
stroke risk is higher in women is something that both physicians and patients
should be focusing on,” said Pilote, whose study results were published in the Journal of the American Medical
Association (JAMA).
Atrial fibrillation is the most common cardiac arrhythmia,
a condition involving an irregular heart rhythm. Generally, the risk of
developing atrial fibrillation increases with age and with other risk factors
such as diabetes, high blood pressure and underlying heart disease. People with
atrial fibrillation have a risk of stroke that is five times greater than those
in the general population
For more about the study, visit http://muhc.ca/newsroom/news/elderly-women-irregular-heartbeat-higher-risk-stroke.